US Expansion And R&D Pipeline Will Build Future Opportunity

Published
12 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
€1.85
32.4% undervalued intrinsic discount
15 Aug
€1.25
Loading
1Y
9.6%
7D
4.5%

Author's Valuation

€1.9

32.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget has decreased future PE multiple from 26.1x to 23.3x and decreased shares outstanding growth rate from -0.1% to -0.1%.